Nimorazole
 | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | P01AB06 (WHO) QP51AA06 (WHO) |
| Identifiers | |
| |
| CAS Number | 6506-37-2 |
| PubChem (CID) | 23009 |
| ChemSpider | 21533 |
| UNII |
469ULX0H4G  Y |
| KEGG |
D07352 Y |
| ECHA InfoCard | 100.026.723 |
| Chemical and physical data | |
| Formula | C9H14N4O3 |
| Molar mass | 226.23 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Nimorazole (INN) is a nitroimidazole anti-infective.[1] It is also being investigated for the treatment of head and neck cancer.[2][3]
References
- ↑ Roy, R. B.; Laird, S. M.; Heasman, L. (1975). "Treatment of trichomoniasis in the female. A comparison of metronidazole and nimorazole". The British Journal of Venereal Diseases. 51 (4): 281–284. PMC 1046566
. PMID 1098732. - ↑ Henk, J. M.; Bishop, K.; Shepherd, S. F. (2003). "Treatment of head and neck cancer with CHART and nimorazole: Phase II study". Radiotherapy and Oncology. 66 (1): 65–70. doi:10.1016/S0167-8140(02)00284-0. PMID 12559522.
- ↑ Clinical trial number NCT01507467 for "IAEA-HypoX. Accelerated Radiotherapy With or Without Nimorazole in Squamous Cell Carcinoma of the Head and Neck" at ClinicalTrials.gov
| Entamoeba |
| ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Acanthamoeba | |||||||||||||||||||||||||||
| |||||||||||||||||||||||||||
| ER |
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GPER |
| ||||||||||
See also: Androgenics • Glucocorticoidics • Mineralocorticoidics • Progestogenics • Steroid hormone metabolism modulators | |||||||||||
This article is issued from Wikipedia - version of the 7/8/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.